The antimicrobial evaluation of twelve natural and hemisynthetic isopimarane diterpenes are reported. The compounds were evaluated against a panel of Gram-positive bacteria, including two methicillin-resistant Staphylococcus aureus (MRSA) strains and one vancomycin-resistant Enterococcus (VRE) strain. Only natural compounds 7,15-isopimaradien-19-ol (1) and 19-acetoxy-7,15-isopimaradien-3β-ol (6) showed promising results. Isopimarane (1) was the most active, showing MIC values between 6.76 µM against S. aureus (ATCC 43866) and 216.62 µM against E. faecalis (FFHB 427483) and E. flavescens (ATCC 49996). Compound (6) showed moderated activity against all tested microorganisms (MIC between value 22.54 and 45.07 µM). These compounds were found to be active against the methicillin-sensitive strains of S. aureus (CIP 106760 and FFHB 29593), showing MIC values of 13.55 (1) and 22.54 (6) µM. Both compounds were also active against vancomycin-resistant E. faecalis (ATCC 51299) (MIC values of 54.14 and 45.07 µM, respectively). In addition, the cytotoxicity of nine compounds 7,15-isopimaradien-3β,19-diol (2); mixture: 15-isopimarene-8β-isobutyryloxy-19-ol and 15-isopimarene-8β-butyryloxy-19-ol (3); 3β-acetoxy-7,15-isopimaradiene-19-ol (5); 19-acetoxy-7,15-isopimaradiene-3β-ol (6); 3β,19-diacetoxy-7,15-isopimaradiene (8); 15-isopimarene-8β,19-diol (9); 19-O-β-d-glucopyranoside-7,15-isopimaradiene (10); lagascatriol-16-O-β-d-glucopyranoside (11) and lagascatriol-16-O-α-d-mannopyranoside (12) was evaluated in the human breast cancer cell line MDA-MB-231. Isopimarane (2) was the only compound showing some cytotoxicity. The IC50 value of compound (2) was 15 µM, suggesting a mild antiproliferative activity against these breast cancer cells.
报道了十二种天然和半合成异皮马兰二萜化合物的抗微生物评价。这些化合物被评估对一系列革兰氏阳性细菌的活性,包括两株耐甲氧西林金黄色葡萄球菌(MRSA)菌株和一株耐万古霉素肠球菌(VRE)菌株。只有天然化合物7,15-异皮马烯-19-醇(1)和19-乙酰氧基-7,15-异皮马烯-3β-醇(6)显示出有希望的结果。异皮马烷(1)表现出最活性,对金黄色葡萄球菌(ATCC 43866)的最小抑菌浓度(MIC)值在6.76 µM,对嗜肠球菌(FFHB 427483)和黄色链球菌(ATCC 49996)的MIC值分别为216.62 µM。化合物(6)对所有测试微生物表现出中等活性(MIC值在22.54和45.07 µM之间)。这些化合物对甲氧西林敏感的金黄色葡萄球菌菌株(CIP 106760和FFHB 29593)表现出活性,MIC值分别为13.55(1)和22.54(6) µM。这两种化合物还对耐万古霉素的嗜肠球菌(ATCC 51299)表现出活性(MIC值分别为54.14和45.07 µM)。此外,对九种化合物7,15-异皮马烯-3β,19-二醇(2); 混合物: 15-异皮马烷-8β-异丁酰氧基-19-醇和15-异皮马烷-8β-丁酰氧基-19-醇(3); 3β-乙酰氧基-7,15-异皮马烯-19-醇(5); 19-乙酰氧基-7,15-异皮马烯-3β-醇(6); 3β,19-二乙酰氧基-7,15-异皮马烯(8); 15-异皮马烷-8β,19-二醇(9); 19-O-β-D-葡萄糖吡喃糖苷-7,15-异皮马烯(10); 拉加卡三醇-16-O-β-D-葡萄糖吡喃糖苷(11)和拉加卡三醇-16-O-α-D-甘露糖吡喃糖苷(12)在人类乳腺癌细胞系MDA-MB-231中进行了细胞毒性评估。异皮马烷(2)是唯一显示出一定细胞毒性的化合物。化合物(2)的IC50值为15 µM,表明对这些乳腺癌细胞具有轻微的抗增殖活性。